Streetbeat News

ETAO

Etao International Co Ltd.

Open

2.80

Mkt cap

9.8M

Volume

154K

High

3.02

P/E Ratio

-0.01

52-wk high

22.00

Low

1.71

Div yield

N/A

52-wk low

1.71

In Friday's pre-market session, health care stocks showed significant movement. Protara Therapeutics led the gainers with a 40.3% increase, while Aesthetic Medical Intl experienced the largest drop among the losers, declining by 17.8%. Other notable movers include Candel Therapeutics and Etao International with substantial gains, and TC BioPharm and Imunon among the losers.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 12:09 pm

Westport Fuel Systems Inc. (NASDAQ:WPRT) shares fell by approximately 10% after reporting a Q4 loss wider than expected. Other stocks experienced significant movements, with notable gainers including Stoke Therapeutics, Inc. (NASDAQ:STOK) and losers like Quhuo Limited (NASDAQ:QH). The movements were attributed to various factors including financial results, clinical trial data, and strategic agreements.

Portfolio Pulse from Avi Kapoor

March 26, 2024 | 5:45 pm

Trading for ETAO was halted but has now resumed as of 8:55:00 AM ET, following an update on quotation resumption times.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:55 pm

Trading for ETAO was halted at 7:50:00 p.m. ET due to pending news. The halt is a temporary measure until the news affecting the company is released.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 11:50 pm

Micron Technology, Inc. (NASDAQ:MU) shares surged by 17.1% in pre-market trading after reporting Q2 results that exceeded expectations and providing strong Q3 guidance. Other stocks also showed significant movement in pre-market trading, with notable gainers including Kaival Brands Innovations Group, Inc. and CuriosityStream Inc., and losers such as Movella Holdings Inc. and Abits Group Inc.

Portfolio Pulse from Avi Kapoor

March 21, 2024 | 12:05 pm

In Wednesday's after-market session, several healthcare stocks experienced significant movements. XTL Biopharmaceuticals, Leap Therapeutics, and Jaguar Health were among the top gainers, with increases of 13.9%, 11.21%, and 10.94% respectively. On the downside, Biophytis, Fresh2 Group, and Etao International Co led the losers, with declines of 20.8%, 16.63%, and 14.01% respectively. Notably, Leap Therapeutics' rise followed its Q4 earnings release, and Avinger also reported its Q4 earnings.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 9:34 pm

U.S. stocks rose after the Federal Reserve left interest rates unchanged, with the Dow, NASDAQ, and S&P 500 all posting gains. Industrials and health care sectors saw mixed performance. Several companies experienced significant stock movements, including ETAO International, XTL Biopharmaceuticals, and TruGolf Holdings seeing sharp increases, while Lifecore Biomedical, Aquestive Therapeutics, and Signet Jewelers reported declines. The Fed's decision to maintain rates between 5.25% and 5.5% was anticipated, aligning with investor expectations.

Portfolio Pulse from Avi Kapoor

March 20, 2024 | 7:22 pm

Lifecore Biomedical's shares plummeted by 31.7% after announcing the conclusion of its strategic evaluation process, management changes, and board reshuffling. Other stocks experienced significant movements, with gainers like ETAO International and XTL Biopharmaceuticals seeing sharp increases due to a reverse stock split and acquisition news, respectively. Losers included NuScale Power Corporation, which dropped 28% following a downgrade by Wells Fargo, and Ontrak, Inc., which fell 26% after a previous day's surge.

Portfolio Pulse from Avi Kapoor

March 20, 2024 | 6:03 pm

Healthcare stocks experienced significant movements in Wednesday's intraday session. XTL Biopharmaceuticals led the gainers with a 95.8% increase, while Lifecore Biomedical topped the losers, declining by 31.4%. Other notable movers include Etao International, Annovis Bio, and Taysha Gene Therapies, which reported Q4 earnings.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 5:31 pm

U.S. stocks were mostly flat as markets awaited the Federal Reserve's interest rate decision. Industrials shares rose by 0.5%, while energy shares fell by 0.6%. Crude oil inventories in the U.S. declined, contrary to market expectations. ETAO International announced a reverse stock split, XTL Biopharmaceuticals plans to acquire The Social Proxy, and TruGolf Holdings expanded its AI technology licensing agreement. Lifecore Biomedical concluded its strategic evaluation, Aquestive Therapeutics priced a public offering, and Signet Jewelers reported disappointing sales and guidance.

Portfolio Pulse from Avi Kapoor

March 20, 2024 | 4:47 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.